【ChiCTR-ONC-14004779】對原發性開角型青光眼、 原發性閉角型青光眼、正常眼壓性青光眼或高眼壓病人施用0.0015% 他氟前列素 (Tafluprost) 滴眼液後的不良反應概況的研究
ChiCTR-ONC-14004779
结束
他氟前列素滴眼液
化学药
他氟前列素滴眼液
2014-06-10
/
-
對原發性開角型青光眼、 原發性閉角型青光眼、正常眼壓性青光眼或高眼壓病人施用0.0015% 他氟前列素 (Tafluprost) 滴眼液後的不良反應概況的研究
對原發性開角型青光眼、 原發性閉角型青光眼、正常眼壓性青光眼或高眼壓病人施用0.0015% 他氟前列素 (Tafluprost) 滴眼液後的不良反應概況的研究
To study on the Adverse Effect Profile of the 0.0015% Tafluprost Ophthalmic Solution in Patients with Primary Open Angle Glaucoma, Primary Angle Closure Glaucoma, Normal Tension Glaucoma or Ocular Hypertension.
连续入组
其它
N/A
/
-
/
20
/
2014-06-21
1990-01-01
/
1) Patients diagnosed with primary open angle glaucoma (POAG), primary angle closure glaucoma (PACG), normal tension glaucoma (NTG) or ocular hypertension (OHT); 2) Switching from latanoprost (other concomitant drugs should not be changed 1 month prior to the switch of medication and are continued during the treatment period); 3) Age between 18 to 70 years; 4) Those who can visit the clinic on the designated day as instructed by the physician.;
请登录查看1) History of intraocular surgery or laser treatment during the three months before informed consent; 2) History of corneal refractive surgery; 3) History of drug allergy (hypersensitivity) to the drugs to be used during the study period (anesthetic ophthalmic solution, fluorescein, etc.) or similar drugs to the investigational product; 4) Presence of any corneal disorder that may interfere with accurate IOP measurement using applanation tonometer; 5) Female patients who are pregnant, nursing or planning a pregnancy; 6) Patients who need to change their pretreating ophthalmic medications (other than latanoprost) during the study.;
请登录查看Santen Pharmaceutical Co., Ltd.
/
Santen Pharmaceutical Co., Ltd.的其他临床试验
The Chinese University of Hong Kong的其他临床试验
- 运动与脑刺激疗愈:促进居住于分间楼宇单位的注意力缺陷多动障碍儿童症状控制的三臂随机对照试验
- Effects of Care partner Online Programme for Managing BPSD and Enhancing Wellbeing (COPE‑BPSD)
- Air purifier and respiratory outcomes in childhood asthma in compromised housing environments: a hybrid effectiveness-implementation trial
- To investigate structural variations (SVs) in autism spectrum disorder (ASD) and related endophenotypes
- Young Adult Community Health Advisor (YACHA)-led Project to Promote Anti-drug Awareness among South Asian Youths and their Family in Hong Kong
- Effects of High-Intensity Interval Training on Physical Fitness, Cognitive and Mental Health in Hong Kong Adolescents with Intellectual Disabilities: A Cluster-Randomized Controlled Trial
- A self-determination theory-based interprofessional intervention to improve diabetes management in the primary health care setting of Hong Kong
- The Effects of Low‐ and High‐Glycemic Index Sport Nutrition Bars on Metabolism and High‐Intensity Interval Training Responses
- An innovative approach to combine intermittent dieting (INTD) with high-intensity interval exercise (HIIE) for curbing central obesity: A comparative randomized controlled trial
- Effectiveness of acceptance-based diabetes self-management (ACT-DSM) for adults with type 2 diabetes for improving diabetes distress and glycaemic control: A randomised controlled trial
- Effects of GABA with Butyrate, GABA/Butyrate-producing Synbiotics on Pain Relief in Fibromyalgia: A Phase II, Multi-Center, Double-Blinded, Randomized-Controlled Trial
- 一项关于声刺激增强慢波睡眠以改善失眠障碍睡眠质量的探索性研究
- The effects of art therapy-based intervention on anxiety children with haematological cancers: a randomised controlled trial
- Effectiveness of Digital CBT-I and BT-I combined ACT for Insomnia and Anxiety Symptoms in Youth: A Randomised Control Trial
- An evidence-based advance care planning programme to promote end-of-life care planning among patients with advanced diseases in the Emergency Department – a feasibility randomised controlled trial
- 养老院老年人使用3D打印髋部保护器的好处
- WhatsApp-assisted prehabilitation programme for adult patient undergoing elective colorectal cancer surgery
- 接纳与承诺疗法(ACT)减轻香港老年人孤独感的随机对照试验
- Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Hepatobiliary and Pancreatic surgery
- 针对中国农村认知障碍症患者家庭照顾者的适应性培训干预的有效性: 一项随机对照可行性试验
最新临床资讯
-
落地临床、抢滩院外,AI康复机器人下一步竞争拼什么?
动脉网-最新2026-08-29
-
再获国际权威学术认可!恒瑞创新药HRS-7535糖尿病肾病Ⅱ期临床研究发表于《柳叶刀》子刊
恒瑞医药2026-08-28
-
贵州百灵2026-08-28
-
癌度2026-08-28
-
UmabsDB2026-08-28
-
扬子江药业集团2026-08-28
-
医药观澜2026-08-28
-
金斯瑞生物2026-08-28
-
科凝生物 Pleryon2026-08-28
-
海创药业2026-08-28
他氟前列素相关推荐
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-08-30
-
2026-08-30
-
2026-08-30
-
摩熵咨询 20 8
-
摩熵咨询 34 36
-
摩熵咨询 20 5
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-08-31
-
2026-08-30
-
2026-08-29
-
摩熵咨询 35 45
-
摩熵咨询 28 45
-
摩熵咨询 34 23
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29

